290 related articles for article (PubMed ID: 33173344)
41. Hepatoid adenocarcinoma of the stomach: a report of three cases.
Ye MF; Tao F; Liu F; Sun AJ
World J Gastroenterol; 2013 Jul; 19(27):4437-42. PubMed ID: 23885160
[TBL] [Abstract][Full Text] [Related]
42. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
43. An analysis of clinicopathological features and prognosis by comparing hepatoid adenocarcinoma of the stomach with AFP-producing gastric cancer.
Liu X; Sheng W; Wang Y
J Surg Oncol; 2012 Sep; 106(3):299-303. PubMed ID: 22389029
[TBL] [Abstract][Full Text] [Related]
44. Efficacy of nintedanib and docetaxel in patients with advanced lung adenocarcinoma treated with first-line chemotherapy and second-line immunotherapy in the nintedanib NPU program.
Corral J; Majem M; Rodríguez-Abreu D; Carcereny E; Cortes ÁA; Llorente M; López Picazo JM; García Y; Domine M; López Criado MP
Clin Transl Oncol; 2019 Sep; 21(9):1270-1279. PubMed ID: 30771085
[TBL] [Abstract][Full Text] [Related]
45. Efficacy of apatinib combined with tegafur gimeracil and oteracil potassium in the second-line treatment of advanced gastric cancer.
Chen H; Xue L; Liu L; Li P
J BUON; 2021; 26(3):917-923. PubMed ID: 34268954
[TBL] [Abstract][Full Text] [Related]
46. Immune-checkpoint inhibitors plus chemotherapy versus chemotherapy as first-line treatment for patients with extensive-stage small cell lung cancer.
Zhou F; Zhao W; Gong X; Ren S; Su C; Jiang T; Zhou C
J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32900864
[TBL] [Abstract][Full Text] [Related]
47. Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction.
Li J; Qin S; Xu J; Xiong J; Wu C; Bai Y; Liu W; Tong J; Liu Y; Xu R; Wang Z; Wang Q; Ouyang X; Yang Y; Ba Y; Liang J; Lin X; Luo D; Zheng R; Wang X; Sun G; Wang L; Zheng L; Guo H; Wu J; Xu N; Yang J; Zhang H; Cheng Y; Wang N; Chen L; Fan Z; Sun P; Yu H
J Clin Oncol; 2016 May; 34(13):1448-54. PubMed ID: 26884585
[TBL] [Abstract][Full Text] [Related]
48. Characteristic analysis of α-fetoprotein-producing gastric carcinoma in China.
Li XD; Wu CP; Ji M; Wu J; Lu B; Shi HB; Jiang JT
World J Surg Oncol; 2013 Oct; 11():246. PubMed ID: 24083471
[TBL] [Abstract][Full Text] [Related]
49. ANGPTL6-mediated angiogenesis promotes alpha fetoprotein-producing gastric cancer progression.
Chen E; Tang C; Peng K; Cheng X; Wei Y; Liu T
Pathol Res Pract; 2019 Aug; 215(8):152454. PubMed ID: 31146977
[TBL] [Abstract][Full Text] [Related]
50. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
[TBL] [Abstract][Full Text] [Related]
51. Efficacy and safety of PD-1/PD-L1 inhibitor plus chemotherapy versus chemotherapy alone as first-line treatment for extensive-stage small cell lung cancer: A systematic review and meta-analysis.
Zhang S; Li S; Cheng Y
Thorac Cancer; 2020 Dec; 11(12):3536-3546. PubMed ID: 33058504
[TBL] [Abstract][Full Text] [Related]
52. Single-cell characteristics and malignancy regulation of alpha-fetoprotein-producing gastric cancer.
Mei Y; Li M; Wen J; Kong X; Li J
Cancer Med; 2023 May; 12(10):12018-12033. PubMed ID: 37017469
[TBL] [Abstract][Full Text] [Related]
53. An unusual cause of significantly elevated blood alpha-fetoprotein levels: a case report and literature review.
Zheng Y; Yao J; Liu J; Zhao F
Front Oncol; 2024; 14():1393074. PubMed ID: 38812781
[TBL] [Abstract][Full Text] [Related]
54. Double cancer of the stomach, one AFP-producing tumor.
Hyodo T; Kawamoto R
J Gastroenterol; 1996 Dec; 31(6):851-4. PubMed ID: 9027651
[TBL] [Abstract][Full Text] [Related]
55. [A multi-center retrospective study of perioperative chemotherapy for gastric cancer based on real-world data].
Ding XW; Zheng ZC; Zhao Q; Zhai G; Liang H; Wu X; Zhu ZG; Wang HJ; He QS; He XL; Du YA; Chen LC; Hua YW; Huang CM; Xue YW; Zhou Y; Zhou YB; Wu D; Fang XD; Dai YG; Zhang HW; Cao JQ; Li LP; Chai J; Tao KX; Li GL; Jie ZG; Ge J; Xu ZF; Zhang WB; Li QY; Zhao P; Ma ZQ; Yan ZL; Zheng GL; Yan Y; Tang XL; Zhou X
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):403-412. PubMed ID: 34000769
[No Abstract] [Full Text] [Related]
56. Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): a propensity score-matched analysis of a single-centre, longitudinal study.
Qian DC; Kleber T; Brammer B; Xu KM; Switchenko JM; Janopaul-Naylor JR; Zhong J; Yushak ML; Harvey RD; Paulos CM; Lawson DH; Khan MK; Kudchadkar RR; Buchwald ZS
Lancet Oncol; 2021 Dec; 22(12):1777-1786. PubMed ID: 34780711
[TBL] [Abstract][Full Text] [Related]
57. Alpha-fetoprotein-producing hepatoid gastric adenocarcinoma in a child presenting with spontaneous gastric perforation.
Emir S; Karakurt N; Karakuş E; Şenel E; Kırsaçlıoğlu C; Demir HA; Orhan D
Turk J Pediatr; 2014; 56(1):88-91. PubMed ID: 24827954
[TBL] [Abstract][Full Text] [Related]
58. Do systemic treatments delivered after Nivolumab result in better outcomes? A bicentric case-control study.
Darrason M; Chatelain E; Ranchon F; Gervaise C; Duruisseaux M; Couraud S
Respir Med Res; 2020 Mar; 77():100-105. PubMed ID: 32512522
[TBL] [Abstract][Full Text] [Related]
59. Treatment effect of apatinib combined chemotherapy as second-line or above therapy in patients with advanced gastric cancer or adenocarcinoma of the gastroesophageal junction.
Zhang F; Yin Y; Ni T; Zhang M; Zhou Z; Sun X; Kuang W; Li P
Pharmazie; 2020 Aug; 75(8):389-394. PubMed ID: 32758339
[TBL] [Abstract][Full Text] [Related]
60. A case report of targeted therapy with apatinib in a patient with advanced gastric cancer and high serum level of alpha-fetoprotein.
Zhu XR; Zhu ML; Wang Q; Xue WJ; Wang YW; Wang RF; Chen SY; Zheng LZ
Medicine (Baltimore); 2016 Sep; 95(37):e4610. PubMed ID: 27631210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
